PDCD1 and melanoma: Currently, for unresectable melanoma, the recommended treatment options include checkpoint inhibitor immunotherapy targeting programmed cell death 1 (PD-1), and inhibitors targeting the mitogen-activated protein kinase (MAPK) pathway.2